These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33394961)

  • 61. Outer Retinal Changes Preceding Secondary Macular Hole Formation Years After Vitreomacular Traction Release Demonstrated on Spectral-Domain OCT.
    Chin AT; Bonini Filho MA; de Carlo TE; Adhi M; Duker JS
    Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):880-2. PubMed ID: 26431305
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Indications and outcomes for intravitreal injection of C
    Guber J; Rusch C; Guber I; Scholl HPN; Valmaggia C
    Sci Rep; 2021 Sep; 11(1):18089. PubMed ID: 34508148
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Spontaneous resolution of vitreomacular traction: a case series.
    Selver OB; Parlak M; Soylemezoglu ZO; Saatci AO
    Clin Exp Optom; 2013 Jul; 96(4):424-7. PubMed ID: 23347070
    [TBL] [Abstract][Full Text] [Related]  

  • 64. COMBINED PNEUMATIC AND ENZYMATIC VITREOLYSIS FOR SEVERE CASES OF VITREOMACULAR TRACTION.
    Yu G; Seto BK; Yamada K; Zeng K; Arroyo JG
    Retin Cases Brief Rep; 2022 Sep; 16(5):631-636. PubMed ID: 32910027
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole.
    Quezada-Ruiz C; Pieramici DJ; Nasir M; Rabena M; Steinle N; Castellarin AA; Dhoot D; Couvillion S; See RF; Avery RL
    Retina; 2015 Jun; 35(6):1144-50. PubMed ID: 25961122
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.
    ; Haller JA; Qin H; Apte RS; Beck RR; Bressler NM; Browning DJ; Danis RP; Glassman AR; Googe JM; Kollman C; Lauer AK; Peters MA; Stockman ME
    Ophthalmology; 2010 Jun; 117(6):1087-1093.e3. PubMed ID: 20299105
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Posterior vitreous detachment in patients with diabetes mellitus.
    Hayashi K; Sato T; Manabe SI; Hirata A; Yoshimura K
    Jpn J Ophthalmol; 2020 Mar; 64(2):187-195. PubMed ID: 32048080
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of intravitreal ocriplasmin treatment for vitreomacular traction in clinical practice.
    Schumann RG; Langer J; Compera D; Luedtke K; Schaumberger MM; Kreutzer T; Mayer WJ; Wolf A; Priglinger SG
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2081-2089. PubMed ID: 28755165
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surgical Results in Ocriplasmin Candidates With Symptomatic Vitreomacular Traction Syndrome.
    Vasquez DH; Altamirano JC; Casaus A; Del Valle RA; Gonzalez R; Gonzalez-De La Rosa A; Navarro-Partida J; Vasquez MA; Santos A
    Curr Eye Res; 2018 Feb; 43(2):208-212. PubMed ID: 29111823
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravitreal Injection of Perfluoropropane is More Efficacious than Sulfur Hexafluoride In Releasing Vitreomacular Traction.
    Čokl N; Globočnik Petrovič M
    Acta Clin Croat; 2018 Jun; 57(2):327-334. PubMed ID: 30431727
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Initial Clinical Experiences Using Ocriplasmin for the Treatment of Vitreomacular Traction with or without a Macular Hole].
    Lenk J; Matthé E; Ventzke S; Pillunat LE; Sandner D
    Klin Monbl Augenheilkd; 2018 Jan; 235(1):73-80. PubMed ID: 28282697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Ciulla TA; Ying GS; Maguire MG; Martin DF; Jaffe GJ; Grunwald JE; Daniel E; Toth CA;
    Ophthalmology; 2015 Jun; 122(6):1203-11. PubMed ID: 25824327
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Factors associated with diabetic macular edema in patients with proliferative diabetic retinopathy.
    O'Fee JR; Juliano J; Moshfeghi AA
    Graefes Arch Clin Exp Ophthalmol; 2022 Jul; 260(7):2191-2200. PubMed ID: 35192029
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assessment of the Vitreomacular Interface Using High-Resolution OCT in a Population-Based Cohort Study of Older Adults.
    Quinn NB; Steel DH; Chakravarthy U; Peto T; Hamill B; Muldrew A; Graham K; Elliott D; Hennessy R; Cruise S; McGuinness B; Young IS; Kee F; Hogg RE
    Ophthalmol Retina; 2020 Aug; 4(8):801-813. PubMed ID: 32335034
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pneumatic Vitreolysis for the Treatment of Vitreomacular Traction Syndrome.
    Özdemir HB; Özdek Ş; Hasanreisoğlu M
    Turk J Ophthalmol; 2019 Sep; 49(4):201-208. PubMed ID: 31486607
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of optical coherence tomography on surgical decision making for epiretinal membranes and vitreomacular traction.
    Do DV; Cho M; Nguyen QD; Shah SM; Handa JT; Campochiaro PA; Zimmer-Galler I; Sung JU; Haller JA
    Retina; 2007 Jun; 27(5):552-6. PubMed ID: 17558315
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High-resolution optical coherence tomography after surgery for vitreomacular traction: a 2-year follow-up.
    Sayegh RG; Georgopoulos M; Geitzenauer W; Simader C; Kiss C; Schmidt-Erfurth U
    Ophthalmology; 2010 Oct; 117(10):2010-7, 2017.e1-2. PubMed ID: 20570362
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Highly reflective foveal region in optical coherence tomography in eyes with vitreomacular traction or epiretinal membrane.
    Tsunoda K; Watanabe K; Akiyama K; Usui T; Noda T
    Ophthalmology; 2012 Mar; 119(3):581-7. PubMed ID: 22115711
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravitreal anti-VEGF treatment in eyes with combined choroidal neovascularisation and vitreomacular traction syndrome.
    Rotsos T; Sagoo MS; daCruz L; Andrews R; Dowler J
    Br J Ophthalmol; 2010 Sep; 94(9):1205-10. PubMed ID: 20558421
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Longitudinal ellipsoid zone and subretinal fluid mapping following ocriplasmin injection in the prospective observational ORBIT trial.
    Lavine JA; Srivastava SK; Dukles N; Reese JL; Ehlers JP
    Br J Ophthalmol; 2020 Mar; 104(3):410-415. PubMed ID: 31248879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.